Harnessing CD40 for Potent Anti-Tumor Immune Responses CD40, a member of the tumor necrosis factor receptor (TNFR) superfamily, plays a pivot … read more 4th Oct 2024 Sana Riaz
B7-H3: A Promising New Target in Tumor Immunotherapy B7-H3, also known as CD276, is a member of the B7 family of immune checkpoint molecule … read more 3rd Oct 2024 Shanza Riaz
TIM-3: Targeting T Cell Exhaustion for Better Immunotherapy Outcomes T cell immunoglobulin and mucin-domain containing-3 (TIM-3) is an immune checkpoint re … read more 3rd Oct 2024 Sana Riaz